About Jungla
Jungla is a Healthcare company based in San Francisco (United States) founded in 2016, and was acquired by Invitae in July 2019. Genomic software solutions for diagnostic development are provided. Jungla has raised $2.75 million across 2 funding rounds from investors including Invitae, Andreessen Horowitz and IndieBio. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Helix, Benchling and Genuity Science; 3 of its 3 listed competitors have raised funding.
Company details
Jungla was founded in 2016 in San Francisco, United States. Genomic software solutions are developed by the company within the biotechnology sector. A proprietary platform is employed to model genetic variants and correlate them with disease states via advanced statistical methods. Operations focus on supporting diagnostic development processes across various applications.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Website jungla.bio
- Social LinkedIn X
- Acquired by Invitae (Jul 2019)
Funding Insights of Jungla
Jungla has successfully raised a total of $2.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.5 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.75M
- Total Rounds 2
- Last Round Series A — $2.5M
- First Round $250,000
(Mar 2016)
- Investors Count 2
All 2 funding rounds of Jungla with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Jungla
Jungla has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Invitae, Andreessen Horowitz and IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in technology sectors are handled by Andreessen Horowitz. | a16z.com | |||
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States | ||
Home-based genetic tests for detecting diseases are provided to individuals. | 2010 | invitae.com | San Francisco, United States |
Investor details for Jungla
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Jungla
7 people are tracked at Jungla (4 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Douglas Fowler | Advisor | Board & advisors |
Vijay Pande | Advisor | Board & advisors |
Birgit Funke | Advisor | Board & advisors |
Tom Schoenherr | Advisor | Board & advisors |
Alex Colavin | Cofounder, Lead of Technical Development | Team |
Jason Reuter | Cofounder, Lead of Functional Genomics | Team |
Samskruthi Padigepati | Machine Learning Engineer | Team |
Complete people profiles for Jungla
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Jungla
4 dated milestones of Jungla across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Jungla is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series A, of $2.5M.
- Exit Acquired by Invitae.
Competitors of Jungla
Jungla has 3 listed competitors in our database, 3 of them funded. They include Helix, Benchling and Genuity Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | Genomic database for clinical research is provided. | ||
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| genuitysci.com | 2013 | Boston, United States | $515M | AI-based omics data analysis solutions are provided to researchers. |
Detailed competitors of Jungla
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Jungla (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jungla
Complete news archive for Jungla
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jungla
Jungla was founded in 2016.
Jungla is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Jungla is a funded company, having raised a total of $2.75M across 2 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Mar 2016.
Jungla was founded in 2016 in San Francisco, United States. Genomic software solutions are developed by the company within the biotechnology sector. A proprietary platform is employed to model genetic variants and correlate them with disease states via advanced statistical methods. Operations focus on supporting diagnostic development processes across various applications.
Jungla's top competitors include Helix, Benchling and Genuity Science.
Jungla has 3 investors. Key investors include Invitae, Andreessen Horowitz, and IndieBio.
Yes. Jungla was acquired by Invitae in July 2019.